162 related articles for article (PubMed ID: 26510948)
1. Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.
Moon SH; Hong SP; Cho YS; Noh TS; Choi JY; Kim BT; Lee KH
J Nucl Cardiol; 2017 Jun; 24(3):892-899. PubMed ID: 26510948
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
[TBL] [Abstract][Full Text] [Related]
3. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
5. Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease.
Takx RA; Ishai A; Truong QA; MacNabb MH; Scherrer-Crosbie M; Tawakol A
J Nucl Med; 2016 Aug; 57(8):1221-5. PubMed ID: 26795284
[TBL] [Abstract][Full Text] [Related]
6. Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals.
Moon SH; Cho YS; Noh TS; Choi JY; Kim BT; Lee KH
JACC Cardiovasc Imaging; 2015 Aug; 8(8):949-56. PubMed ID: 26189117
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of bone marrow
Lee JW; Lee SC; Kim HJ; Lee SM
Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
[TBL] [Abstract][Full Text] [Related]
8. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
[TBL] [Abstract][Full Text] [Related]
9. Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals.
Cho SG; Park KS; Kim J; Kang SR; Kwon SY; Seon HJ; Jabin Z; Kim YJ; Jeong GC; Song M; Song HC; Min JJ; Bom HS
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):129-140. PubMed ID: 27683281
[TBL] [Abstract][Full Text] [Related]
10. Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
Moon SH; Noh TS; Cho YS; Hong SP; Hyun SH; Choi JY; Kim BT; Lee KH
Angiology; 2015 May; 66(5):472-80. PubMed ID: 24904182
[TBL] [Abstract][Full Text] [Related]
11. Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by
Lee HJ; Lee CH; Kim S; Hwang SY; Hong HC; Choi HY; Chung HS; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Metabolism; 2017 Feb; 67():72-79. PubMed ID: 28081780
[TBL] [Abstract][Full Text] [Related]
12. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
13. Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
Pak K; Kim SJ; Kim IJ; Kim DU; Kim K; Kim H; Kim SJ
Nuklearmedizin; 2014; 53(2):26-31. PubMed ID: 24305850
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
[TBL] [Abstract][Full Text] [Related]
15. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
[TBL] [Abstract][Full Text] [Related]
16. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
17. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
[TBL] [Abstract][Full Text] [Related]
18.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT of the non-malignant liver in an increasingly obese world population.
Keramida G; Peters AM
Clin Physiol Funct Imaging; 2020 Sep; 40(5):304-319. PubMed ID: 32529712
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
